Alpha Teknova Inc

TKNO | $2.155 -17.12% -20.65% 7.4K

(0.0% 1d) (-24.9% 1m) (-0.5% 1y) (0.0% 2d) (-18.8% 3d) (-12.4% 7d) (952.9% volume)
Earnings Calendar: 2024-03-11
Market Cap: $ 87,974,399
https://www.teknova.com
Sec Filling | Patents | 193 employees

Teknova is expediting clinical breakthroughs in the life sciences by providing custom products and reagents for bioprocessing, bioproduction, and molecular diagnostics. With a focus on agility and customization, Teknova delivers research-grade and GMP products including cell culture media and supplements, protein and nucleic acid purification buffers, and molecular biology reagents for a multitude of established and emerging applications, including cell and gene therapy, mRNA therapeutics, genomics, and synthetic biology. Teknova's proprietary processes enable the manufacture and delivery of high quality, custom, made-to-order products on short turnaround times and at scale across all stages of development, including commercialization.

diagnostics gene therapies t-cell

add to watch list Paper trade email alert is off

Press-releases

Teknova Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-11 (Crawled : 20:00) - globenewswire.com
TKNO | $2.155 -17.12% -20.65% 7.4K

Professional, Scientific, and T...

| -30.13% | O: -5.25% H: 4.45% C: -0.4%
year financial results

Teknova to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
Published: 2024-02-21 (Crawled : 21:00) - globenewswire.com
TKNO | $2.155 -17.12% -20.65% 7.4K

Professional, Scientific, and T...

| -29.67% | O: 0.0% H: 5.5% C: -2.33%
report year financial results

Teknova Reports Third Quarter 2023 Financial Results
Published: 2023-11-09 (Crawled : 21:00) - globenewswire.com
TKNO | $2.155 -17.12% -20.65% 7.4K

Professional, Scientific, and T...

| 4.98% | O: -1.49% H: 4.04% C: -1.52%
financial results

Teknova to Report Third Quarter 2023 Financial Results on November 9, 2023
Published: 2023-10-26 (Crawled : 12:00) - globenewswire.com
TKNO | $2.155 -17.12% -20.65% 7.4K

Professional, Scientific, and T...

| 13.44% | O: 4.84% H: 11.28% C: -2.56%
report financial results

Teknova Launches Latest Proprietary AAV-Tek™ Product and End-to-End Plasmid Workflow Solutions to Streamline Therapeutic Process Development
Published: 2023-09-27 (Crawled : 12:00) - globenewswire.com
TKNO | $2.155 -17.12% -20.65% 7.4K

Professional, Scientific, and T...

| -27.74% | O: 31.85% H: 10.91% C: -19.74%
solutions

Teknova Announces Closing of $22.9 Million Concurrent Registered Direct Offering and Private Placement and Amends Credit Facility
Published: 2023-09-19 (Crawled : 20:00) - globenewswire.com
TKNO | $2.155 -17.12% -20.65% 7.4K

Professional, Scientific, and T...

| 17.88% | O: 1.68% H: 8.79% C: 3.3%
direct offering

Teknova Announces Up to $22.9 Million Concurrent Registered Direct Offering and Private Placement
Published: 2023-09-18 (Crawled : 12:00) - globenewswire.com
TKNO | $2.155 -17.12% -20.65% 7.4K

Professional, Scientific, and T...

| 14.05% | O: -5.41% H: 7.71% C: 2.29%
direct offering

Teknova Announces New Board Member, Martha J. Demski
Published: 2023-08-16 (Crawled : 12:00) - globenewswire.com
TKNO | $2.155 -17.12% -20.65% 7.4K

Professional, Scientific, and T...

| -24.1% | O: -2.16% H: 9.19% C: 3.31%
EQ | $1.79 -3.24% 0.0% 93K

Health Technology

| 145.03% | O: -4.37% H: 14.96% C: 13.57%
CMRX | $0.904 -1.75% -2.23% 480K

Health Technology

| -7.9% | O: -1.9% H: 4.08% C: -2.04%

Teknova Reports Second Quarter 2023 Financial Results
Published: 2023-08-10 (Crawled : 20:00) - globenewswire.com
TKNO | $2.155 -17.12% -20.65% 7.4K

Professional, Scientific, and T...

| -24.64% | O: -4.64% H: 7.12% C: 7.12%
financial results

Teknova Announces Opening of New GMP-Certified Facility, Increasing Manufacturing Capacity for Custom, High-Quality Life Sciences Reagents
Published: 2023-08-09 (Crawled : 12:00) - globenewswire.com
TKNO | $2.155 -17.12% -20.65% 7.4K

Professional, Scientific, and T...

| -28.23% | O: 0.0% H: 1.7% C: -10.88%
life capacity sciences

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001850902-23-000045	4	2023-12-01	2023-11-30	Buy	P	3587	22924
0001850902-23-000043	4	2023-11-15	2023-11-14	Sell	J	15000	18834